Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: Single-center experience

Catheterization and Cardiovascular Interventions

Volumn 60, Issue 2, 2003, Pages 152-158

  Orrego, Pedro Silva ^a,b   Delgado, Anabella ^a   Piccalò, Giacomo ^a   Salvadè, Paolo ^a   Bonacina, Edgardo ^a   Klugmann, Silvio ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Niguarda Hospital ^*  (Italy)

Author keywords

Acute myocardial infarction; Angioplasty; Embolization

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION; ATHEROSCLEROTIC PLAQUE; BALLOON OCCLUSION; CLINICAL ARTICLE; CORONARY ARTERY; DEVICE; FEMALE; HUMAN; MALE; REPERFUSION INJURY; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BALLOON OCCLUSION; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; ECHOCARDIOGRAPHY; EQUIPMENT DESIGN; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE; TREATMENT OUTCOME;

EID: 0141678974     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10638     Document Type: Article

References (31)

1. Zahn R, Schiele R, Schneider S, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry. J Am Coll Cardiol 2001;37:1827-1835.
2. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-391.
3. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction (CADILLAC trial). N Eng J Med 2002;346:957-966.
4. Neumann FJ, Blasini R, Schmitt C, et al. A. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after placement of coronary-artery stents in acute myocardial infarction. Circulation 1998;98:2695-2701.
5. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-391.
6. Block PC, Elmer D, Fallon JT. Release of atherosclerotic debris after transluminal angioplasty. Circulation 1982;65:950-952.
7. MacDonald RG, Feldman RI, Conti CR, et al. Thromboembolic complications of coronary angioplasty. Am J Cardiol 1984;54: 916-917.
8. Colavita PG, Ideker RE, Reimer KA, et al. The spectrum of pathology associated with transluminal coronary angioplasty during acute myocardial infarction. J Am Coll Cardiol 1986;8:855-860.
9. de Morais CF, Lopez EA, Checchi H, et al. Percutaneous transluminal coronary angioplasty: histopathologic analysis of nine necropsy cases. Wirchow Arch 1986;410:195-202.
10. Menke DM, Jordan MD, Aust CH, et al. Histologic evidence of distal coronary thromboembolism: a complication of acute proximal coronary artery thrombolysis therapy. Chest 1986;9:614-616.
11. Saber RS, Edwards WD, Bailey KR, et al. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J Am Coll Cardiol 1993;22:1283-1288.
12. Henriques JPS, Zijistra F, Ottervanger JP, de Boer MJ, van't Hof AWJ, Hoorntje JCA, Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-1117.
13. Carlino M, De Gregorio J, Di Mario M, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty: experience with a new temporary occlusion and aspiration system. Circulation 1999;99:3221-3223.
14. Baim DS, Wahr D, George B, et al., on behalf of the Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002;105:285-290.
15. Belli G, Pezzano A, De Biase AM, et al. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Cathet Cardiovasc Intervent 2000;50:362-370.
16. Beran G, Lang I, Schreiber W, et al. Intracoronary thrombectomy with the X-Sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective randomized study. Circulation 2002;105: 2355-2360.
17. Claeys MJ, Bosmans J, Venstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction. Circulation 1999;99:1972-1977.
18. Grube E, Schofer J, Webb J, et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting saphenous vein grafts: the Saphenous Vein Graft Angioplasty free of Emboli (SAFE) trial study group. Am J Cardiol 2002;89:941-945.
19. Grube E, Gerkens U, Yeung A, et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001;104: 2436-2441.
20. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101: 570-580.
21. Topol EJ, Leya F, Pinkerton CA, et al., for the CAVEAT study group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-227.
22. Holmes DR, Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995;91:1966-1974.
23. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35; 1134-1141.
24. Kern MJ, Puri S, Bach RG, et al. Abnormal coronary flow velocity reserve after coronary artery stenting in patients: role of relative coronary reserve to assess potential mechanisms. Circulation 1999;100:2491-2498.
25. Matthew TR, Ohman EM, Maas A, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001;37:9-18.
26. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the no-reflow phenomenon: a predictor of comlications anf left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
27. Iwakura K, Ito H, Nishikawa L, et al. Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon. Am J Cardiol 1999;84:415-419.
28. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-1956.
29. Rezkalla S, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-662.
30. Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol 2000;36:22-24.
31. Poli A, Fetiveau R, Vandoni P, et al. Integrated analysis of myocardial blush and st-segment elevation recovery after successful primary angioplasty. real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002;106:313-318.